Does SODIUM, MONOBASIC Cause Hyperlipidaemia? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Hyperlipidaemia have been filed in association with SODIUM, MONOBASIC. This represents 19.9% of all adverse event reports for SODIUM, MONOBASIC.
45
Reports of Hyperlipidaemia with SODIUM, MONOBASIC
19.9%
of all SODIUM, MONOBASIC reports
45
Deaths
42
Hospitalizations
How Dangerous Is Hyperlipidaemia From SODIUM, MONOBASIC?
Of the 45 reports, 45 (100.0%) resulted in death, 42 (93.3%) required hospitalization, and 42 (93.3%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SODIUM, MONOBASIC. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does SODIUM, MONOBASIC Cause?
Hyponatraemia (185)
Stress (183)
General physical health deterioration (182)
Multiple organ dysfunction syndrome (182)
Sepsis (180)
Vomiting (178)
Appendicitis (177)
Ascites (177)
Appendicolith (176)
Abdominal distension (174)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which SODIUM, MONOBASIC Alternatives Have Lower Hyperlipidaemia Risk?
SODIUM, MONOBASIC vs SODIUM MONOFLUOROPHOSPHATE
SODIUM, MONOBASIC vs SODIUM NITROPRUSSIDE
SODIUM, MONOBASIC vs SODIUM OXYBATE
SODIUM, MONOBASIC vs SODIUM PHENYLBUTYRATE
SODIUM, MONOBASIC vs SODIUM PHENYLBUTYRATE\TAURURSODIOL